0000885590-14-000021.txt : 20140212
0000885590-14-000021.hdr.sgml : 20140212
20140212164308
ACCESSION NUMBER: 0000885590-14-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140211
FILED AS OF DATE: 20140212
DATE AS OF CHANGE: 20140212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weldon Ryan
CENTRAL INDEX KEY: 0001564233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 14600880
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
CITY: LAVAL
STATE: A8
ZIP: H7L 4A8
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-02-11
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001564233
Weldon Ryan
2150 ST. ELZEAR BLVD. WEST
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
0
1
0
0
EVP, Company Group Chairman
Common Stock, no par value
2014-02-11
4
M
0
11000
0
A
103823
D
Common Stock, no par value
2014-02-11
4
F
0
5707
0
D
98116
D
Restricted Share Units
2014-02-11
4
M
0
11000
0
D
Common Stock
11000
11000
D
This represents the number of units vested on the performance-based RSUs ("PSUs") that were previously reported on the original Form 4. The initial grant was reported to vest based on total shareholder return (TSR) between a price of $62.62 starting on January 28, 2013 and the average stock price for the 20 trading days starting on each measurement dates: 25% on October 28, 2015, 50% on January 28, 2016 and 25% on April 28, 2016. Unit vesting is contingent on TSR performance between 10% and 30% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. The PSU award may still payout two times grant value.
This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units.
by: Nicholas Zanoni for Ryan Weldon
2014-02-12